glp-1 drug updates Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Market Overview: GLP-1 Agonists and
Description
As GLP-1 patents expire and Indian pharma giants launch generic versions, treatments once reserved for the affluent could become accessible to millions
doi: 10.3810/pgm.2012.11.2613
Decision Rule : Focus on the three primary active compoundsSemaglutide, Tirzepatide, and Liraglutidedue to their dominant market share and clinical evidence
However, your health care provider might consider alternatives such as Wegovy, Mounjaro, or Saxenda, all of which are GLP-1 medications but not all are FDA-approved for weight loss specifically.
Illness, infection, or surgery
